CFG
ABBV icon

Cooper Financial Group’s AbbVie ABBV Stock Holding History

Cooper Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.69M Buy
14,096
+2,636
+23% +$676K 0.29% 62
2026
Q2 		$2.88M Buy
11,460
+2,042
+22% +$439K 0.24% 77
2026
Q1 		$2.05M Buy
9,418
+229
+2% +$50.8K 0.21% 94
2025
Q4 		$2.1M Buy
9,189
+470
+5% +$107K 0.22% 78
2025
Q3 		$2.02M Buy
8,719
+230
+3% +$46.8K 0.22% 75
2025
Q2 		$1.58M Sell
8,489
-1,569
-16% -$292K 0.19% 95
2025
Q1 		$2.11M Sell
10,058
-183
-2% -$35.6K 0.28% 69
2024
Q4 		$1.82M Buy
10,241
+668
+7% +$123K 0.22% 86
2024
Q3 		$1.89M Sell
9,573
-2,792
-23% -$521K 0.25% 72
2024
Q2 		$2.12M Sell
12,365
-663
-5% -$110K 0.31% 62
2024
Q1 		$2.37M Buy
13,028
+1,587
+14% +$274K 0.39% 44
2023
Q4 		$1.77M Buy
11,441
+659
+6% +$96.1K 0.32% 58
2023
Q3 		$1.61M Sell
10,782
-326
-3% -$47.9K 0.39% 57
2023
Q2 		$1.5M Buy
11,108
+712
+7% +$104K 0.37% 62
2023
Q1 		$1.66M Buy
10,396
+722
+7% +$110K 0.45% 50
2022
Q4 		$1.56M Buy
9,674
+2,432
+34% +$373K 0.48% 46
2022
Q3 		$972K Buy
7,242
+691
+11% +$99.2K 0.35% 72
2022
Q2 		$1M Buy
6,551
+1,137
+21% +$174K 0.36% 70
2022
Q1 		$878K Sell
5,414
-297
-5% -$43.1K 0.33% 65
2021
Q4 		$773K Sell
5,711
-3,782
-40% -$447K 0.29% 87
2021
Q3 		$1.02M Buy
9,493
+1,122
+13% +$128K 0.21% 71
2021
Q2 		$943K Buy
8,371
+1,698
+25% +$191K 0.19% 79
2021
Q1 		$722K Sell
6,673
-4,558
-41% -$488K 0.16% 91
2020
Q4 		$1.2M Buy
11,231
+4,848
+76% +$466K 0.25% 70
2020
Q3 		$559K Buy
6,383
+839
+15% +$79K 0.16% 92
2020
Q2 		$544K Buy
5,544
+352
+7% +$31K 0.18% 81
2020
Q1 		$396K Buy
5,192
+1,126
+28% +$95.9K 0.17% 90
2019
Q4 		$360K Buy
4,066
+626
+18% +$52K 0.14% 91
2019
Q3 		$261K Buy
+3,440
New +$236K 0.12% 114

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Cooper Financial Group's ABBV Position: Q3 2026 in Review

Cooper Financial Group increased its AbbVie (ABBV) stake by 23% in Q3 2026, buying an estimated $676K and bringing the position to 14,096 shares worth $3.69M. The position accounts for 0.29% of the portfolio, ranked #62.

Cooper Financial Group first reported a position in ABBV in Q3 2019 and has held it in 29 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Cooper Financial Group held 14,096 shares of AbbVie worth $3.69M as of Q3 2026.
  • Cooper Financial Group bought 2,636 AbbVie shares in Q3 2026, an estimated $676K.
  • AbbVie made up 0.29% of Cooper Financial Group's portfolio in Q3 2026, its #62 holding.
  • Cooper Financial Group first reported a position in AbbVie in Q3 2019 and has held it in 29 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Cooper Financial Group's 13F filing for Q3 2026, filed 7 Oct 2026.